Compounds > ro 22-1319
Page last updated: 2024-09-03

ro 22-1319 and domperidone

ro 22-1319 has been researched along with domperidone in 1 studies

Compound Research Comparison

Studies
(ro 22-1319)		Trials
(ro 22-1319)		Recent Studies (post-2010)
(ro 22-1319)		Studies
(domperidone)		Trials
(domperidone)		Recent Studies (post-2010) (domperidone)
23301,977275468

Protein Interaction Comparison

ProteinTaxonomyro 22-1319 (IC50)domperidone (IC50)
Solute carrier family 22 member 2Homo sapiens (human)7.9
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)1.332
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.614
Alpha-2A adrenergic receptorHomo sapiens (human)2.74
D(2) dopamine receptorHomo sapiens (human)0.0026
Alpha-2B adrenergic receptorHomo sapiens (human)2.125
Alpha-2C adrenergic receptorHomo sapiens (human)1.011
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.614
Alpha-1D adrenergic receptorHomo sapiens (human)1.065
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.037
5-hydroxytryptamine receptor 2CHomo sapiens (human)1.332
Sodium-dependent serotonin transporterHomo sapiens (human)3.055
Histamine H1 receptorHomo sapiens (human)1.344
Mu-type opioid receptorHomo sapiens (human)4.218
D(3) dopamine receptorHomo sapiens (human)0.018
Kappa-type opioid receptorHomo sapiens (human)6.994
5-hydroxytryptamine receptor 2BHomo sapiens (human)2.6
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0052
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.1447
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kakigi, T; Kaneda, H; Shintani, T; Tanimoto, K; Terada, T1

Other Studies

1 other study(ies) available for ro 22-1319 and domperidone

ArticleYear
Comparison of prolactin responses to D-1 and D-2 antagonists in rats: Ro 22-1319 is a potent D-2 antagonist.
    Biological psychiatry, 1989, Feb-15, Volume: 25, Issue:4

    Topics: Animals; Antipsychotic Agents; Benzazepines; Domperidone; Fluphenazine; Haloperidol; Isoquinolines; Male; Perphenazine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2

1989